NEUTEC PHARMA LIMITED

Company number 03297187 ·

Dissolved

Overview

Company type
Private Limited Company
Incorporated
1996-12-30
Dissolved
2025-09-23
Registered office
2nd Floor, The Westworks Building White City Place, 195 Wood Lane, London, United Kingdom, W12 7FQ
Postcode
W12 7FQ
Capital
7,726,389 GBP
Accounts category
Full
Charges
0 outstanding

Accounts

Last made up to
2023-12-31
Financial year end
31 December

Confirmation statement

Last statement dated
2024-12-30
View filing history →

Nature of business (SIC)

  • 86900 Other human health activities

Officers 3 current · 31 resigned

Sandeep GUPTA Director
Chief Financial Officer Appointed 2025-05-12
REBECCA ANN WESTON Secretary
Appointed 2016-02-01
GROUP ACCOUNTANT Appointed 2010-11-19

View all officers and resignations →

Group structure

Controlled by NOVARTIS PHARMACEUTICALS UK LIMITED — since 2016-04-06

From persons-with-significant-control filings on the public register.

Modern slavery statement

Registered a modern slavery statement for 2025 (period to 2024-12-31) as part of the NOVARTIS PHARMACEUTICALS UK LIMITED group statement — 2 years on the registry.

Read the statement summary on the government modern slavery statement registry. Contains public sector information licensed under the Open Government Licence v3.0.

Previous company names

NameDate changed
NEUTEC PHARMA PLC2006-10-13
HALLCO 125 PLC1997-02-26

Previous registered addresses 5

AddressChanged on
2ND FLOOR, THE WESTWORKS BUILDING, WHITE CITY PLACE, 195 WOOD LANE, LONDON, W12 7FQ, UNITED KINGDOM2019-12-16
200 FRIMLEY BUSINESS PARK, FRIMLEY, CAMBERLEY, SURREY, GU16 7SR2019-12-16
2ND FLOOR CLINICAL SCIENCES, BUILDING CENTRAL MANCHESTER AND, MANCHESTER CHILDRENS HOSPITAL, OXFORD ROAD MANCHESTER M13 9WL2007-01-24
2ND FLOOR, CLINICAL SCIENCES BUILDING, MANCHESTER ROYAL INFIRMARY, OXFORD ROAD MANCHESTER M13 9WL2004-07-30
ST JAMES'S COURT BROWN STREET, MANCHESTER, M2 2JF1997-06-26

The class of 1996

54%

of the 314 companies in this sector incorporated in 1996 are still active today; 45% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →